Abstract |
A natural plant product, SP-303, was administered by small-particle aerosol to influenza A/HK virus-infected mice and RSV-infected cotton rats. Aqueous SP-303 at 2 mg/ml in the Collison nebulizer reservoir generated an aerosol with an output of 26 micrograms/l and a particle size distribution of 1.4 microns +/- 4.6 (MMAD +/- GSD). SP-303 at a dosage of 0.5-9.4 mg/kg per day administered for 3-4 days significantly increased both the rate and duration of survival of mice lethally infected with influenza A/HK virus. SP-303 was toxic to mice at 16 mg/kg per day as indicated by weight loss and a decrease in the duration of survival compared to control animals. From these data, a maximum therapeutic index (T.I.) of 12 was calculated. SP-303 given 3-4 days at dosages of 1.3-9.8 mg/kg per day was effective in reducing the pulmonary titer of RSV in infected cotton rats. However, at the 18.7 mg/kg per day dose a significant weight loss compared to control animals was observed; a T.I. of < or = 14 was estimated. These experiments demonstrate that aerosol administration of SP-303 was effective in the treatment of influenza A-infected mice and of RSV-infected cotton rats.
|
Authors | B E Gilbert, P R Wyde, S Z Wilson, L R Meyerson |
Journal | Antiviral research
(Antiviral Res)
Vol. 21
Issue 1
Pg. 37-45
(May 1993)
ISSN: 0166-3542 [Print] Netherlands |
PMID | 8317921
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Aerosols
- Antiviral Agents
- Biopolymers
- Plant Extracts
- Catechin
- crofelemer
|
Topics |
- Administration, Inhalation
- Aerosols
- Animals
- Antiviral Agents
(pharmacokinetics, pharmacology)
- Biopolymers
- Catechin
(analogs & derivatives, pharmacokinetics, pharmacology)
- Dose-Response Relationship, Drug
- Humans
- Influenza A virus
- Influenza, Human
(drug therapy, microbiology)
- Mice
- Mice, Inbred ICR
- Plant Extracts
(pharmacology)
- Rats
- Respiratory Syncytial Viruses
- Respirovirus Infections
(drug therapy, microbiology)
- Therapeutic Equivalency
|